Jingwei Bai

Jingwei Bai

Auto-generated profile, based on publicly available information

Jingwei Bai

School of Pharmaceutical Sciences, Tsinghua University, Beijing, China

Research Focus & Metrics

Academic Career Length

19Years (2008-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
12 November 2021 in Chemical Science
Verified
Journal Article
Open access
PDF file
ZCZhijie Chen
Zhijie Chen
ZWZhenqin Wang
Zhenqin Wang
YXYang Xu
Yang Xu
XZXiaochun Zhang
Xiaochun Zhang
BTBoxue Tian
Boxue Tian
JBJingwei Bai
Jingwei Bai
A new technique for single molecular peptide sequencing is demonstrated by translocation of ssDNA-conjugated-peptide through MspA nanopore which is regulated by a DNA helicase motor.


1 February 2022 in Nature Communications
Verified
Journal Article
Open access
PDF file
HZHua Zhang
Hua Zhang
LZLin Zhao
Lin Zhao
JJJingjing Jiang
Jingjing Jiang
JZJie Zheng
Jie Zheng
LYLi Yang
Li Yang
XDXiangfeng Duan
Xiangfeng Duan
As cancer is increasingly considered a metabolic disorder, it is postulated that serum metabolite profiling can be a viable approach for detecting the presence of cancer. By multiplexing mass spectrometry fingerprints from two independent nanostructured matrixes through machine learning for highly sensitive detection and high throughput analysis, we report a laser desorption/ionization (LDI) mass spectrometry-based liquid biopsy for pan-cancer screening and classification. The Multiplexed Nanomaterial-Assisted LDI for Cancer Identification (MNALCI) is applied in 1,183 individuals that include 233 healthy controls and 950 patients with liver, lung, pancreatic, colorectal, gastric, thyroid cancers from two independent cohorts. MNALCI demonstrates 93% sensitivity at 91% specificity for distinguishing cancers from healthy controls in the internal validation cohort, and 84% sensitivity at 84% specificity in the external validation cohort, with up to eight metabolite biomarkers identified. In addition, across those six different cancers, the overall accuracy for identifying the tumor tissue of origin is 92% in the internal validation cohort and 85% in the external validation cohort. The excellent accuracy and minimum sample consumption make the high throughput assay a promising solution for non-invasive cancer diagnosis.

6 September 2020 in Advanced Functional Materials
Verified
Journal Article
Closed access
PDF file
BWBolun Wang
Bolun Wang
YSYufei Sun
Yufei Sun
HDHanyuan Ding
Hanyuan Ding
XZXuan Zhao
Xuan Zhao
LZLei Zhang
Lei Zhang
Kai LiuKai Liu
Kai Liu

1 March 2019 in Talanta
Verified
Journal Article
Closed access
RTRong Tian
Rong Tian
WNWeihua Ning
Weihua Ning
MCMinghai Chen
Minghai Chen
CZCheng Zhang
Cheng Zhang
QLQingwen Li
Qingwen Li
JBJingwei Bai
Jingwei Bai

17 October 2022 in Biosensors and Bioelectronics
Verified
Journal Article
Closed access
SLShanglin Li
Shanglin Li
BLBao Li
Bao Li
XLXinyue Li
Xinyue Li
CLCe Liu
Ce Liu
XQXiao Qi
Xiao Qi
PLPeng Liu
Peng Liu